Polygenic hazard score predicts aggressive and fatal prostate cancer in multi-ethnic populations

作者: Minh-Phuong Huynh-Le , Chun Chieh Fan , Roshan Karunamuni , Wesley K Thompson , Maria Elena Martinez

DOI: 10.1101/19012237

关键词:

摘要: Abstract Objectives A polygenic hazard score (PHS1)—weighted sum of 54 single-nucleotide polymorphism genotypes—was previously associated with age at prostate cancer (PCa) diagnosis and improved PCa screening accuracy in Europeans. Performance more diverse populations is unknown. We evaluated PHS association multi-ethnic populations. Design PHS1 was adapted for compatibility genotype data from the OncoArray project (PHS2) tested diagnosis, aggressive death. Setting Multiple international institutions. Participants Men available PRACTICAL consortium who were not included development/validation. Main Outcomes Measures PHS2 via Cox proportional hazards models (any of: Gleason ≥7, stage T3-T4, PSA≥10 ng/mL, nodal/distant metastasis), PCa-specific Results 80,491 men various self-reported race/ethnicities (30,575 controls, 49,916 cases; genetic ancestry groups: 71,856 European, 6,253 African, 2,382 Asian). Median last follow-up 70 years (IQR 63-76); 3,983 deaths, 5,806 other 70,702 still alive. had 46 polymorphisms: 24 directly genotyped 22 acceptable proxies (r2 ≥0.94). dataset (z=54, p Conclusions strongly a dataset. stratifies Asian, African by risk any, aggressive, fatal PCa. Summary boxes What already known on this topic Genetic stratification can identify greater predisposition developing cancer, but these may worsen health disparities, as most have only been validated European Europeans unknown study adds In race/ethnicities, cancer.

参考文章(49)
Terry M. Therneau, Hongzhe Li, Computing the Cox model for case cohort designs. Lifetime Data Analysis. ,vol. 5, pp. 99- 112 ,(1999) , 10.1023/A:1009691327335
Bob Djavan, Anton Stangelberger, Matthias Waldert, Prostate Cancer in Elderly Men Reviews in urology. ,vol. 10, pp. 111- 119 ,(2008)
Ying Han, Lisa B. Signorello, Sara S. Strom, Rick A. Kittles, Benjamin A. Rybicki, Janet L. Stanford, Phyllis J. Goodman, Sonja I. Berndt, John Carpten, Graham Casey, Lisa Chu, David V. Conti, Kristin A. Rand, W. Ryan Diver, Anselm J.M. Hennis, Esther M. John, Adam S. Kibel, Eric A. Klein, Suzanne Kolb, Loic Le Marchand, M. Cristina Leske, Adam B. Murphy, Christine Neslund-Dudas, Jong Y. Park, Curtis Pettaway, Timothy R. Rebbeck, Susan M. Gapstur, S. Lilly Zheng, Suh-Yuh Wu, John S. Witte, Jianfeng Xu, William Isaacs, Sue A. Ingles, Ann Hsing, Douglas F. Easton, Rosalind A. Eeles, Fredrick R. Schumacher, Stephen Chanock, Barbara Nemesure, William J. Blot, Daniel O. Stram, Brian E. Henderson, Christopher A. Haiman, , , Generalizability of established prostate cancer risk variants in men of African ancestry International Journal of Cancer. ,vol. 136, pp. 1210- 1217 ,(2015) , 10.1002/IJC.29066
Michel Bolla, Theodorus M. de Reijke, Geertjan Van Tienhoven, Alphonsus C.M. Van den Bergh, Jorg Oddens, Philip M.P. Poortmans, Eliahu Gez, Paul Kil, Atif Akdas, Guy Soete, Oleg Kariakine, Elsbietha M. van der Steen-Banasik, Elena Musat, Marianne Piérart, Murielle E. Mauer, Laurence Collette, Duration of androgen suppression in the treatment of prostate cancer. The New England Journal of Medicine. ,vol. 360, pp. 2516- 2527 ,(2009) , 10.1056/NEJMOA0810095
Thomas J. Wang, Martin G. Larson, Daniel Levy, Emelia J. Benjamin, Eric P. Leip, Torbjorn Omland, Philip A. Wolf, Ramachandran S. Vasan, Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death New England Journal of Medicine. ,vol. 350, pp. 655- 663 ,(2004) , 10.1056/NEJMOA031994
Hsin-Chieh Yeh, Smoking, Smoking Cessation, and Risk for Type 2 Diabetes Mellitus Annals of Internal Medicine. ,vol. 152, pp. 10- 17 ,(2010) , 10.7326/0003-4819-152-1-201001050-00005
Michael Leitzmann, Sabine Rohrmann, Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates. Clinical Epidemiology. ,vol. 4, pp. 1- 11 ,(2012) , 10.2147/CLEP.S16747
Christopher A. Haiman, Gary K. Chen, William J. Blot, Sara S. Strom, Sonja I. Berndt, Rick A. Kittles, Benjamin A. Rybicki, William B. Isaacs, Sue A. Ingles, Janet L. Stanford, W. Ryan Diver, John S. Witte, Stephen J. Chanock, Suzanne Kolb, Lisa B. Signorello, Yuko Yamamura, Christine Neslund-Dudas, Michael J. Thun, Adam Murphy, Graham Casey, Xin Sheng, Peggy Wan, Loreall C. Pooler, Kristine R. Monroe, Kevin M. Waters, Loic Le Marchand, Laurence N. Kolonel, Daniel O. Stram, Brian E. Henderson, Characterizing Genetic Risk at Known Prostate Cancer Susceptibility Loci in African Americans PLoS Genetics. ,vol. 7, pp. e1001387- ,(2011) , 10.1371/JOURNAL.PGEN.1001387
A. M. D. Wolf, R. C. Wender, R. B. Etzioni, I. M. Thompson, A. V. D'Amico, R. J. Volk, D. D. Brooks, C. Dash, I. Guessous, K. Andrews, C. DeSantis, R. A. Smith, American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010 CA: A Cancer Journal for Clinicians. ,vol. 60, pp. 70- 98 ,(2010) , 10.3322/CAAC.20066
Donna P. Ankerst, Josef Hoefler, Sebastian Bock, Phyllis J. Goodman, Andrew Vickers, Javier Hernandez, Lori J. Sokoll, Martin G. Sanda, John T. Wei, Robin J. Leach, Ian M. Thompson, Prostate cancer prevention trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer Urology. ,vol. 83, pp. 1362- 1368 ,(2014) , 10.1016/J.UROLOGY.2014.02.035